A detailed history of Kings Path Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kings Path Partners LLC holds 8,037 shares of ABT stock, worth $942,418. This represents 0.38% of its overall portfolio holdings.

Number of Shares
8,037
Previous 8,037 -0.0%
Holding current value
$942,418
Previous $835 Million 9.72%
% of portfolio
0.38%
Previous 0.39%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $809,567 - $903,680
8,037 New
8,037 $835 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.